A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease.

Rieger, Theodore R; Allen, Richard J; Musante, Cynthia J

Rieger, Theodore R; Allen, Richard J; Musante, Cynthia J.

Afiliación

Rieger TR; Quantitative Systems Pharmacology, Early Clinical Development, Pfizer Inc, Cambridge, MA, United States.
Allen RJ; Quantitative Systems Pharmacology, Early Clinical Development, Pfizer Inc, Cambridge, MA, United States.
Musante CJ; Quantitative Systems Pharmacology, Early Clinical Development, Pfizer Inc, Cambridge, MA, United States.

Front Pharmacol ; 13: 910789, 2022.

Article en En | MEDLINE | ID: mdl-35928268

Palabras clave

NAFLD; QSP; liver; mathematical modeling; metabolism; steatosis; triglyceride

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google